Register
Forgot your password?

Dynamics of perioperative glycemia after off-pump and on-pump coronary artery bypass grafting in patients with type 2 diabetes mellitus

Authors: Kudryashova E.N., Berdibekov B.Sh., Bulaeva N.I., MerzlyakovV.Yu., Batov S.M., Salomov M.A., Dzhidzalova D.Kh., Khoroshikh L.V., Tarasova K.A., Golukhova E.Z.

Company: Bakoulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russian Federation

For correspondence:  Sign in or register.

Type:  Original articles


DOI: https://doi.org/10.24022/1997-3187-2023-17-4-491-501

For citation: Kudryashova E.N., Berdibekov B.Sh., Bulaeva N.I., Merzlyakov V.Yu., Batov S.M., Salomov M.A., Dzhidzalova D.Kh., Khoroshikh L.V., Tarasova K.A., Golukhova E.Z. Dynamics of perioperative glycemia after off-pump and on-pump coronary artery bypass grafting in patients with type 2 diabetes mellitus. Creative Cardiology. 2023; 17 (4): 491–501 (in Russ.). DOI: 10.24022/1997-3187-2023-17-4-491-501

Received / Accepted:  04.11.2023 / 24.11.2023

Keywords: on-pump coronary artery bypass grafting hyperglycemia diabetes mellitus

Download
Full text:  

 

Abstract

Objective. To provide an analysis of glycose level dynamics and factors that influence hyperglycemia in the early postoperative period in patients with type 2 diabetes mellitus (DM) who underwent off-pump coronary artery bypass (OPCAB) and on-pump coronary artery bypass (ONCAB).

Material and methods. A retrospective study included 40 patients who underwent ONCAB and 40 patients who underwent OPCAB. The average age of the patients was 61.4±6.8 years, 59 (73.8%) patients were male. Plasma glucose of more than 10 mmol/L for 24 h after cardiac surgery was taken as an indicator of poor glycemic control.

Results. Analyzing the dynamics of glycemia after coronary artery bypass grafting (CABG) (ONCAB and OPCAB) at different stages of the perioperative period, statistically significant patterns were not found between the initial glucose levels before CABG surgery (7.1 [6.0–8.5] and 7.4 [6.8–8.2] mmol/l, respectively, p=0.436). However, on the first and second days after surgery, statistically significant higher glucose levels were observed in the group undergoing ONCAB compared to OPCAB group (11.0 [9.1–13.3] versus 8.6 [7.8–11.6] mmol/l, p=0.005 and 9.0 [7.3–10.7] versus 7.5 [6.9–8.7] mmol/l, p=0.025, respectively). Also, on the 3rd day after surgery and before discharge, the blood glucose level between the groups of ONCAB and OPCAB did not differ statistically significantly (7.3 [6.2–8.9] versus 6.8 [6.4–7.7] mmol/l, p=0.711 and 6.7 [6.5–8.4] versus 6.8 [6.2–7.8] mmol/l, p=0.760, respectively). Using multivariate binary logistic analysis was found that male gender (odds ratio (OR) 4.00; 95% confidence interval (CI) 1.23–13.04; p=0.021) and ONCAB as the method of revascularization (OR 3.02; 95% CI 1.15–7.91; p=0.024) were predictors of the poor glucose control within first day after surgery.

Conclusion. According to the results of the present study, OPCAB is associated with better postoperative glucose control compared with glucose maintenance in patients undergoing ONCAB.

References

  1. Fox C.S. Cardiovascular disease risk factors, type 2 diabetes mellitus, and the Framingham Heart Study. Trends Cardiovasc. Med. 2010; 20 (3): 90–5. DOI: 10.1016/j.tcm.2010.08.001
  2. Dedov I.I., Shestakova M.V., Vikulova O.K., ZheleznyakovaA.V., Isakov M.A., Sazonova D.V., Mokrysheva N.G. Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022. Diabetes Mellitus. 2023; 26 (2): 104–23 (in Russ.). DOI: 10.14341/DM13035
  3. International Diabetes Federation, IDF Diabetes Atlas. International Diabetes Federation, Brussels, Belgium, 10th ed., 2021.
  4. Cavender M.A., Steg P.G., Smith S.C., Jr., Eagle K., Ohman E.M., Goto S. et al. Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death. Outcomes at 4 years from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Circulation. 2015; 132 (10): 923–31. DOI: 10.1161/CIRCULATIONAHA.114.014796
  5. Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U. et al. ESC Scientific Document Group, 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2019; 40 (2): 87–165. DOI: 10.1093/eurheartj/ehy394
  6. Golukhova E.Z., Kuznetsova E.V. Myocardial revascularization in patients with type 2 diabetes mellitus: an overview of modern techniques. Diabetes Mellitus. 2016; 19 (5): 406–13 (in Russ.). DOI: 10.14341/DM8031
  7. Sebranek J.J., Lugli A.K., Coursin D.B. Glycaemic control in the perioperative period. Br. J. Anaesth. 2013; 111 (1): I18–34. DOI: 10.1093/bja/aet381
  8. Lazar H.L., McDonnell M., Chipkin S.R., Furnary A.P., Engelman R.M., Sadhu A.R. et al. Society of thoracic surgeons blood glucose guideline task force. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann. Thorac. Surg. 2009; 87 (2): 663–9. DOI: 10.1016/j.athoracsur.2008.11.011
  9. Fudulu D., Benedetto U., Pecchinenda G.G., Chivasso P., Bruno V.D., Rapetto F. et al. Current outcomes of off-pump versus on-pump coronary artery bypass grafting: evidence from randomized controlled trials. J. Thorac. Dis. 2016; 8 (10): 758– 71. DOI: 10.21037/jtd.2016.10.80
  10. ElSayed N.A., Aleppo G., Aroda V.R., Bannuru R.R., Brown F.M., Bruemmer D. et al. 16. Diabetes care in the hospital: standards of care in diabetes – 2023. Diabetes Care. 2023; 46 (1): S267–78. DOI: 10.2337/dc23-S016
  11. Chamberlain J.J., Rhinehart A.S., Shaefer Ch.F., Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes. Clinical guidelines. Ann. Intern. Med. 2016; 164 (8): 542–52. DOI: 10.7326/M15-3016
  12. Dungan K., Chapman J., Braithwaite S.S., Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care. 2007; 30 (2): 403–9. DOI: 10.2337/dc06-1679
  13. Zabolotskikh I.B., Malyshev Yu.P., Dunts P.V., Lebedinskii K.M., Leiderman I.N., Neimark М.I. et al. Perioperative management of adult patients with concomitant diabetes mellitus: guidelines of the All-Russian public organization “Federation of Anesthesiologists and Reanimatologists” (second revision). Annals of Critical Care. 2023; 1: 14–33 (in Russ.). DOI: 10.21320/1818-474X-2023-1-14-33
  14. Sousa-Uva M., Head S.J., Milojevic M., Collet J.P., Landoni G., Castella M. et al. 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. Eur. J. Cardiothorac. Surg. 2018; 53 (1): 5–33. DOI: 10.1093/ejcts/ezx314
  15. Malmberg K., Rydén L., Wedel H., Birkeland K., Bootsma A., Dickstein K. et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur. Heart J. 2005; 26 (7): 650–61. DOI: 10.1093/eurheartj/ehi199
  16. Estrada C.A., Young J.A., Nifong L.W., Chitwood W.R., Jr. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann. Thorac. Surg. 2003; 75 (5): 1392–9. DOI: 10.1016/s0003-4975(02)04997-4
  17. Furnary A.P., Gao G., Grunkemeier G.L., Wu Y., Zerr K.J., Bookin S.O. et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 2003; 125 (5): 1007–21. DOI: 10.1067/mtc.2003.181
  18. Doenst T., Wijeysundera D., Karkouti K., Zechner C., MagantiM., Rao V. et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J. Thorac. Cardiovasc. Surg. 2005; 130 (4): 1144. DOI: 10.1016/j.jtcvs.2005.05.049
  19. Fish L.H., Weaver T.W., Moore A.L., Steel L.G. Value of postoperative blood glucose in predicting complications and length of stay after coronary artery bypass grafting. Am. J. Cardiol. 2003; 92 (1): 74–6. DOI: 10.1016/s0002-9149(03)00472-7 20. McAlister F.A., Man J., Bistritz L., Amad H., Tandon P. Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabetes Care. 2003; 26 (5): 1518–24. DOI: 10.2337/diacare.26.5.1518
  20. Gandhi G.Y., Nuttall G.A., Abel M.D., Mullany C.J., Schaff H.V., Williams B.A. et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin. Proc. 2005; 80 (7): 862–6. DOI: 10.4065/80.7.862
  21. Anderson R.E., Brismar K., Barr G., Ivert T. Effects of cardiopulmonary bypass on glucose homeostasis after coronary artery bypass surgery. Eur. J. Cardiothorac. Surg. 2005; 28 (3): 425–30. DOI: 10.1016/j.ejcts.2005.05.025
  22. Marik P.E. Tight glycemic control in acutely ill patients: low evidence of benefit, high evidence of harm! Intensive Care Med. 2016; 42 (9): 1475–7. DOI: 10.1007/s00134-016-4299-2
  23. Gunst J., Van den Berghe G. Blood glucose control in the ICU: don’t throw out the baby with the bathwater! Intensive Care Med. 2016; 42 (9): 1478–81. DOI: 10.1007/s00134-016-4350-3
  24. Umpierrez G., Cardona S., Pasquel F., Jacobs S., Peng L., Unigwe M. et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes Care. 2015; 38 (9): 1665–72. DOI: 10.2337/dc15-0303
  25. Finfer S., Chittock D.R., Su S.Y., Blair D., Foster D. et al. Intensive versus conventional glucose control in critically ill patients. N. Engl. J. Med. 2009; 360 (13): 1283–97. DOI: 10.1056/NEJMoa0810625
  26. Berdibekov B.Sh., Bulaeva N.I., Golukhova E.Z. Perioperative medical therapy in adult patients undergoing cardiac surgery. Creative Cardiology. 2023; 17 (1): 34–49 (in Russ.). DOI: 10.24022/1997–3187–2023-17-1-34-49
  27. Siegelaar S.E., Hermanides J., Oudemans-van Straaten H.M., van der Voort P.H., Bosman R.J., Zandstra D.F. et al. Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study. Crit. Care. 2010; 14 (6): R224. DOI: 10.1186/cc9369
  28. Knapik P., Nadziakiewicz P., Urbanska E., Saucha W., Herdynska M., Zembala M. Cardiopulmonary bypass increases postoperative glycemia and insulin consumption after coronary surgery. Ann. Thorac. Surg. 2009; 87 (6): 1859–65. DOI: 10.1016/j.athoracsur.2009.02.066
  29. Williams J.B., Peterson E.D., Albrecht Á.S., Li S., Hirji S.A., Ferguson T., Jr. et al. Glycemic control in patients undergoing coronary artery bypass graft surgery: Clinical features, predictors, and outcomes. J. Crit. Care. 2017; 42: 328–33. DOI: 10.1016/j.jcrc.2017.09.013

About Authors

  • Elena N. Kudryashova, Cardiologist; ORCID
  • Bektur Sh. Berdibekov, Cardiologist; ORCID
  • Naida I. Bulaeva, Cand. Biol. Sci., Associate Professor, Head of Department, Cardiologist; ORCID
  • Vadim Yu. Merzlyakov, Dr. Med. Sci., Professor, Cardiovascular Surgeon, Head of Department; ORCID
  • Sergey M. Batov, Cardiovascular Surgeon; ORCID
  • Machmadsharif A. Salomov, Researcher, Cardiovascular Surgeon; ORCID
  • Diana Kh. Dzhidzalova, Cardiologist; ORCID
  • Ludmila V. Khoroshikh, Cardiologist; ORCID
  • Ksenia A. Tarasova, Postgraduate; ORCID
  • Elena Z. Golukhova, Dr. Med. Sci., Professor, Academician of RAS, Director; ORCID

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by